Oral Cephalexin Dosing for 12.4 kg Child
For a child weighing 12.4 kg, administer oral cephalexin 310-620 mg divided into 3-4 doses daily (approximately 310 mg every 12 hours or 155 mg every 6 hours), using the standard pediatric dosing range of 25-50 mg/kg/day. 1
Dosing Calculation
The FDA-approved pediatric dosing for cephalexin is 25-50 mg/kg/day in divided doses 1. For this 12.4 kg child:
- Standard dosing: 25 mg/kg/day = 310 mg/day
- Higher dosing (for more severe infections): 50 mg/kg/day = 620 mg/day
Practical Administration Options
For Standard Infections (Skin/Soft Tissue, Streptococcal Pharyngitis):
Option 1 - Twice Daily Dosing:
- 155 mg (approximately 6 mL of 125 mg/5 mL suspension) every 12 hours
- Total daily dose: 310 mg/day (25 mg/kg/day)
Option 2 - Four Times Daily Dosing:
- 75-80 mg (approximately 3 mL of 125 mg/5 mL suspension) every 6 hours
- Total daily dose: 300-320 mg/day
For More Severe Infections or Methicillin-Susceptible Staphylococcus aureus:
According to IDSA/PIDS guidelines, oral cephalexin 75-100 mg/kg/day in 3 or 4 doses is preferred for MSSA infections 2, 3, 2, 3, 2:
- 930-1,240 mg/day divided into 3-4 doses
- Practically: 310 mg every 8 hours (TID) or 235 mg every 6 hours (QID)
- Using 250 mg/5 mL suspension: approximately 6 mL every 8 hours
Key Clinical Considerations
Indication-Specific Dosing:
- For streptococcal pharyngitis: The total daily dose may be divided every 12 hours 1
- For otitis media: 75-100 mg/kg/day in 4 divided doses is required 1
- For MSSA skin infections or bone/joint infections: 75-100 mg/kg/day in 3-4 doses 2
Common Pitfall: Recent research shows that pediatric patients weighing over 20 kg are at highest risk for dosing errors, particularly overdosing when prescribers fail to apply maximum dose caps 4. For this 12.4 kg child, this is not yet a concern, but be aware that maximum single doses should not exceed 500 mg for standard infections.
Duration: Continue β-hemolytic streptococcal infections for at least 10 days 1. Cystitis therapy should continue for 7-14 days 1.
Emerging Evidence: Recent pharmacokinetic studies support less frequent dosing regimens. Research demonstrates that 45 mg/kg three times daily (maximum 1.5 g/dose) achieves appropriate pharmacodynamic targets and is well-tolerated 5, 6. For this 12.4 kg child, this would be approximately 558 mg (22 mL of 125 mg/5 mL suspension) three times daily for serious MSSA infections.